0
Signin
countryflagCA

888-969-2592

RY 174.39 2.4016% SHOP 149.115 2.5974% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 78.325 0.1214% ENB 60.6 1.3039% BN 80.4 1.9787% TRI 226.27 0.7525% CNQ 48.285 2.2771% CP 104.53 1.6038% CNR 151.74 1.5459% BMO 132.69 0.9203% BNS 78.845 0.1715% CSU 4600.2002 2.157% CM 91.15 0.474% MFC 45.79 1.6878% ATD 78.38 1.5285% NGT 60.14 0.0499% TRP 70.15 1.977% SU 57.44 0.5954%

DRI Healthcare Trust

Healthcare CA DHT.U

9.75CAD
0.33(3.50%)

Last update at 2024-01-23T18:41:00Z

Day Range

9.759.75
LowHigh

52 Week Range

4.459.61
LowHigh

Fundamentals

  • Previous Close 9.42
  • Market Cap530.52M
  • Volume8903
  • P/E Ratio5.85
  • Dividend Yield3.18%
  • EBITDA61.93M
  • Revenue TTM113.08M
  • Revenue Per Share TTM2.83
  • Gross Profit TTM 93.03M
  • Diluted EPS TTM1.61

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Income before tax 11.60M 21.56M -
Minority interest - - -
Net income 11.60M 21.56M -
Selling general administrative 7.56M 9.46M -
Selling and marketing expenses - - -
Gross profit - - -
Reconciled depreciation 59.27M 41.84M -
Ebit 18.98M 24.44M -0.00217M
Ebitda - - -
Depreciation and amortization - - -
Non operating income net other - - -
Operating income - - -
Other operating expenses 4.29M 5.41M 5.41M
Interest expense 6.63M 2.24M 0.00000M
Tax provision - - -
Interest income 5.76M 1.91M -
Net interest income -0.86900M -0.33100M -
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense - - -
Total revenue 79.87M 73.33M -
Total operating expenses - - -
Cost of revenue - - -
Total other income expense net - - -
Discontinued operations - - -
Net income from continuing ops 11.60M 21.56M -
Net income applicable to common shares 11.60M 21.56M -0.00217M
Preferred stock and other adjustments - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Total assets 633.42M 436.69M -
Intangible assets 518.13M 293.66M -
Earning assets - - -
Other current assets 0.47M 0.57M -
Total liab 261.08M 57.71M -
Total stockholder equity 372.34M 378.99M -
Deferred long term liab - - -
Other current liab 9.98M 12.10M -
Common stock 373.58M 401.51M 0.00001M
Capital stock 373.58M 374.03M -
Retained earnings -1.23600M 4.95M -0.00036M
Other liab 0.56M 0.14M -
Good will - - -
Other assets 50.38M 50.61M -
Cash 36.69M 61.71M -
Cash and equivalents - - -
Total current liabilities 50.10M 18.97M 0.00036M
Current deferred revenue - - -
Net debt 208.30M - -
Short term debt - - -
Short long term debt - - -
Short long term debt total - - -
Other stockholder equity - -27.47500M 0.00001M
Property plant equipment - - -
Total current assets 64.90M 92.43M 0.00001M
Long term investments - - -
Net tangible assets -145.79300M 85.33M -0.00035M
Short term investments - - -
Net receivables 27.75M 30.15M -
Long term debt - - -
Inventory - - -
Accounts payable 5.54M 1.56M 0.00036M
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total - - -
Capital lease obligations - - -
Long term debt total - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Investments -273.66800M -372.33500M -
Change to liabilities -0.59800M 0.62M 0.00217M
Total cashflows from investing activities -273.66800M -372.33500M -372.33500M
Net borrowings 201.40M -24.39800M -24.39800M
Total cash from financing activities 171.17M 342.18M 0.00006M
Change to operating activities 1.29M -0.85200M -0.85200M
Net income 11.60M 21.56M -0.00217M
Change in cash -25.02600M 61.71M 0.00006M
Begin period cash flow 61.71M 0.00000M -
End period cash flow 36.69M 61.71M -
Total cash from operating activities 77.47M 91.86M 91.86M
Issuance of capital stock 0.00000M 400.00M -
Depreciation 59.27M 41.84M 41.84M
Other cashflows from investing activities 0.83M 1.49M 1.49M
Dividends paid 20.23M 3.68M 3.68M
Change to inventory - - -
Change to account receivables 3.77M 27.97M 27.97M
Sale purchase of stock -7.26300M -5.47800M -
Other cashflows from financing activities -2.74100M -24.26300M -24.26300M
Change to netincome 2.14M 0.72M 0.72M
Capital expenditures 274.50M 324.33M 0.00000M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital 4.46M 27.74M -
Stock based compensation - - -
Other non cash items 2.14M 0.80M -
Free cash flow -197.03100M -232.46300M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
DHT-U
DRI Healthcare Trust		 0.33 3.50% 9.75 5.85 17.89 4.69 0.95 1.94
BHC
Bausch Health Companies Inc		 -0.11 0.96% 11.37 - 2.23 0.50 18.74 2.56 9.13
CURA
Curaleaf Holdings Inc.		 -0.175 5.93% 2.77 - 138.89 1.62 1.66 1.73 10.18
TLRY
Tilray Inc		 0.03 1.38% 1.83 - 1000.00 2.17 0.36 1.69 -2.299
CRON
Cronos Group Inc		 0.06 2.15% 2.85 - - 10.18 0.70 0.02 -1.9458

Reports Covered

Stock Research & News

View All

Profile

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

DRI Healthcare Trust

1 First Canadian Place, Toronto, ON, Canada, M5X 1B1

Key Executives

Name Title Year Born
Mr. Behzad Khosrowshahi CPA CEO & Trustee of DRI Capital Inc. NA
Mr. Chris Anastasopoulos CPA Exec. VP & CFO of DRI Capital Inc. NA
Mr. Stewart Michael Busbridge Exec. VP & COO of DRI Capital Inc. NA
Mr. Navin Cyriac Jacob Exec. VP, Head of Investments & Research - DRI Capital Inc. NA
Ms. Rhizza Marbella VP of Corp. Accounting, Fin. & Investor Relations of DRI Capital Inc NA
Mr. David Levine Director of Investor Relations NA
Ms. Faith Bowen Chief Compliance Officer of DRI Capital Inc. NA
Ms. Gurminder Chahal VP of HR - DRI Capital Inc. NA
Dr. John McCulloch Ph.D. Managing Director of DRI Capital Inc NA
Mr. Babak Farahmand Sr. VP of Asset Operations & Analytics - DRI Capital Inc. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.